Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system

Journal of Pharmacology and Experimental Therapeutics

Volumn 303, Issue 2, 2002, Pages 549-556

  Tao, Rui ^a   Auerbach, Sidney B ^b  

^a RUTGERS UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; ENDOMORPHIN 1; ENDOMORPHIN 2; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; LIGAND; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; OPIATE RECEPTOR; RECEPTOR SUBTYPE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; EXTRACELLULAR SPACE; FOREBRAIN; MALE; MESENCEPHALON; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, OPIOID; ANIMALS; CENTRAL NERVOUS SYSTEM; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALIN, LEUCINE-2-ALANINE; MALE; MICRODIALYSIS; MICROINJECTIONS; NALTREXONE; NUCLEUS ACCUMBENS; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SEROTONIN;

EID: 0036827560     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.037861     Document Type: Article

References (40)

1. Acosta CG and Lopez HS (1999) Delta opioid receptor modulation of several voltage-dependent Ca(2+) currents in rat sensory neurons. J Neurosci 19:8337-8448.
2. Alt A, Clark MJ, Woods JH, and Traynor JR (2002) Mu and delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells. Br J Pharmacol 135:217-225.
3. Banks WA, Trentman TL, Kastin AJ, and Galina ZH (1988) The general anesthesia induced by various drugs differentially affects analgesia and its variability. Pharmacol Biochem Behav 31:397-403.
4. Basbaum AI and Fields HL (1984) Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7:309-338.
5. Chiu TT, Yung LY, and Wong YH (1996) Inverse agonistic effect of ICI-174,864 on the cloned delta-opioid receptor: Role of G protein and adenylyl cyclase activation. Mol Pharmacol 50:1651-1657.
6. Dykstra KH, Hsiao JK, Morrison PF, Bungay PM, Mefford IN, Scully MM, and Dedrick RL (1992) Quantitative Examination of Tissue Concentration Profiles Associated with Microdialysis. J Neurochem 58:931-940.
7. Fields HL, Heinricher MM, and Mason P (1991) Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 14:219-245.
8. Grahn RE, Maswood S, McQueen MB, Watkins LR, and Maier SF (1999) Opioid-dependent effects of inescapable shock on escape behavior and conditioned fear responding are mediated by the dorsal raphe nucleus. Behav Brain Res 99:153-167.
9. Haigler HJ (1978) Morphine: Effects on serotonergic neurons and neurons in areas with a serotenergic input. Eur J Pharmacol 51:361-376.
10. Jacobs BL and Fornal CA (1991) Activity of brain serotonergic neurons in the behaving animal, Pharmacol Rev 43:563-578.
11. Johnson SW and North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483-488.
12. Jolas T and Aghajanian GK (1997) Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro. Brain Res 755:229-245.
13. Kalyuzhny AE, Arvidsson U, Wu W, and Wessendorf MW (1996) mu-Opioid and deltaopioid receptors are expressed in brainstem antinociceptive circuits: Studies using immunocytochemistry and retrograde tract-tracing. J Neurosci 16:6490-6503.
14. Knapp RJ, Malatynska E, Collins N, Fang L, Wang JY, Hruby VJ, Roeske WR, and Yamamura HI (1995) Molecular biology and pharmacology of cloned opioid receptors. FASEB J 9:516-525.
15. Lutfy K and Maidment NT (2000) Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test. Br J Pharmacol 131:1684-1688.
16. Ma QP and Han JS (1992) Neurochemical and morphological evidence of an antinociceptive neural pathway from nucleus raphe dorsalis to nucleus accumbens in the rabbit. Brain Res Bull 28:931-936.
17. Maldonado R, Feger J, Fournie-Zaluski MC, and Roques BP (1990) Differences in physical dependence induced by selective mu or delta opioid agonists and by endogenous enkephalins protected by peptidase inhibitors. Brain Res 520:247-254.
18. Mansour A, Fox CA, Akil H, and Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications. Trends 18:22-29.
19. Martin-Schild S, Gerall AA, Kastin AJ, and Zadina JE (1999) Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J Comp Neurol 405:450-471.
20. Mason P (1999) Central mechanisms of pain modulation. Curr Opin Neurobiol 9:436-441.
21. Monroe PJ, Kradel BK, Smith DL, and Smith DJ (1995) Opioid effects on spinal [3H]5-hydroxytryptamine release are not related to their antinociceptive action. Eur J Pharmacol 272:51-56.
22. Neal CR Jr, Mansour A, Reinscheid R, Nothacker HP, Civelli O, Akil H, and Watson SJ Jr (1999) Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: Comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J Comp Neurol 412:563-605.
23. Neilan CL, Akil H, Woods JH, and Traynor JR (1999) Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: Identification of non-peptide delta-inverse agonists. Br J Pharmacol 128:556-562.
24. North RA (1986) Opioid receptor types and membrane ion channels. Trends Neurosci 9:114-117.
25. Pan Z, Hirakawa N, and Fields HL (2000) A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin. Neuron 26:515-522.
26. Pan ZZ, Tershner SA, and Fields HL (1997) Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor. Nature (Lond) 389:382-385.
27. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates, 2nd Ed, Academic Press, Sydney.
28. Recht LD and Pasternak GW (1987) Effects of beta-funaltrexamine on radiolabeled opioid binding. Eur J Pharmacol 140:209-214.
29. Rivot JP, Pointis D, and Besson JM (1988) Morphine increases 5-HT metabolism in the nucleus raphe magnus: An in vivo study in freely moving rats using 5-hydroxyindole electrochemical detection. Brain Res 446:333-342.
30. Spampinato U, Esposite E, Romandini S, and Samanin R (1985) Changes of serotonin and dopamine metabolism in various forebrain areas of rats injected with morphine either systemically or in the raphe nuclei dorsalis and medianus. Brain Res 328:89-95.
31. Spanagel R, Herz A, and Shippenberg TS (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: An in vivo microdialysis study. J Neurechem 55:1734-1740.
32. Tao R and Auerbach SB (1994a) Anesthetics block morphine-induced increases in serotonin release in rat CNS. Synapse 18:307-314.
33. Tao R and Auerbach SB (1994b) Increased extracellular serotonin in rat brain after systemic or intraraphe administration of morphine. J Neurochem 63:517-524.
34. Tao R and Auerbach SB (1995) Involvement of the dorsal raphe but not median raphe nucleus in morphine-induced increases in serotonin release in the rat forebrain. Neuroscience 68:553-561.
35. Tao R and Auerbach SB (2000) Regulation of serotonin release by GABA and excitatory amino acids. J Psychopharmacol 14:100-113.
36. B receptors in midbrain raphe nuclei and forebrain of rats. Br J Pharmacol 119:1375-1384.
37. Tao R, Ma Z, and Auerbach SB (2000) Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin. J Pharmacol Exp Ther 294:571-579.
38. Thompson AC, Zapata A, Justice JB Jr, Vaughan RA, Sharpe LG, and Shippenberg TS (2000) Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine. J Neurosci 20:9333-9340.
39. Xu H, Lu YF, Partilla JS, Pinto J, Calderon SN, Matecka D, Rice KC, Lai J, Porreca F, Ananthan S, and Rothman RB (1998) Opioid peptide receptor studies. 8. One of the mouse brain deltaNCX binding sites is similar to the cloned mouse opioid delta receptor, further evidence for heterogeneity of delta opioid receptors. Peptides 19:343-350.
40. Zadina JE, Hackler L, Ge LJ, and Kastin AJ (1997) A potent and selective endogenous agonist for the mu-opiate receptor. Nature (Lond) 386:499-502.